These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 36502288)

  • 41. Effect of glucagon-like peptide-1 receptor agonists on fat distribution in patients with type 2 diabetes: A systematic review and meta-analysis.
    Duan K; Yan X; Gao Z; Hou Y; Lv X; Song G
    J Diabetes Investig; 2022 Jul; 13(7):1149-1160. PubMed ID: 35191185
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Roles of increased glycaemic variability, GLP-1 and glucagon in hypoglycaemia after Roux-en-Y gastric bypass.
    Tharakan G; Behary P; Wewer Albrechtsen NJ; Chahal H; Kenkre J; Miras AD; Ahmed AR; Holst JJ; Bloom SR; Tan T
    Eur J Endocrinol; 2017 Dec; 177(6):455-464. PubMed ID: 28855269
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glucagon-like peptide-1 receptor agonists versus insulin glargine for type 2 diabetes mellitus: A systematic review and meta-analysis of randomized controlled trials.
    Li WX; Gou JF; Tian JH; Yan X; Yang L
    Curr Ther Res Clin Exp; 2010 Aug; 71(4):211-38. PubMed ID: 24688145
    [TBL] [Abstract][Full Text] [Related]  

  • 44. EndoBarrier gastrointestinal liner. Delineation of underlying mechanisms and clinical effects.
    Rohde U
    Dan Med J; 2016 Nov; 63(11):. PubMed ID: 27808040
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The relation between postprandial glucagon-like peptide-1 release and insulin sensitivity before and after bariatric surgery in humans with class II/III obesity.
    Gilijamse PW; Demirkiran A; van Wagensveld BA; Ackermans MT; Romijn JA; Nieuwdorp M; Ter Horst KW; Serlie MJ
    Surg Obes Relat Dis; 2021 Aug; 17(8):1440-1448. PubMed ID: 34083134
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Role of GLP-1 Analogs in the Management of Diabetes and its Secondary Complication.
    Sivakumar PM; Premkumar B; Prabhawathi V; Prabhakar PK
    Mini Rev Med Chem; 2021; 21(20):3166-3182. PubMed ID: 33888049
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Hyperinsulinemic hypoglycemia after Roux-en-Y gastric bypass: unraveling the role of gut hormonal and pancreatic endocrine dysfunction.
    Rabiee A; Magruder JT; Salas-Carrillo R; Carlson O; Egan JM; Askin FB; Elahi D; Andersen DK
    J Surg Res; 2011 May; 167(2):199-205. PubMed ID: 21414635
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Tumour Risk with Once-Weekly Glucagon-Like Peptide-1 Receptor Agonists in Type 2 Diabetes Mellitus Patients: A Systematic Review.
    Guo X; Yang Q; Dong J; Liao L; Zhang W; Liu F
    Clin Drug Investig; 2016 Jun; 36(6):433-41. PubMed ID: 26979594
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Glucagon-like peptide-1 receptor agonists for antipsychotic-associated cardio-metabolic risk factors: A systematic review and individual participant data meta-analysis.
    Siskind D; Hahn M; Correll CU; Fink-Jensen A; Russell AW; Bak N; Broberg BV; Larsen J; Ishøy PL; Vilsbøll T; Knop FK; Kisely S; Ebdrup BH
    Diabetes Obes Metab; 2019 Feb; 21(2):293-302. PubMed ID: 30187620
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular safety and benefits of GLP-1 receptor agonists.
    Dalsgaard NB; Brønden A; Vilsbøll T; Knop FK
    Expert Opin Drug Saf; 2017 Mar; 16(3):351-363. PubMed ID: 28102093
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evidence for Relationship Between Early Dumping and Postprandial Hypoglycemia After Roux-en-Y Gastric Bypass.
    Øhrstrøm CC; Worm D; Kielgast UL; Holst JJ; Hansen DL
    Obes Surg; 2020 Mar; 30(3):1038-1045. PubMed ID: 31907828
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Diagnosis and management of post-bariatric surgery hypoglycemia.
    Alkhaled L; Al-Kurd A; Butsch WS; Kashyap SR; Aminian A
    Expert Rev Endocrinol Metab; 2023; 18(6):459-468. PubMed ID: 37850227
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Glucagon-Like Peptide-1 Receptor Agonists-Use in Clinical Practice.
    Tricò D; Solini A
    Adv Chronic Kidney Dis; 2021 Jul; 28(4):328-336. PubMed ID: 34922689
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Weight loss between glucagon-like peptide-1 receptor agonists and bariatric surgery in adults with obesity: A systematic review and meta-analysis.
    Sarma S; Palcu P
    Obesity (Silver Spring); 2022 Nov; 30(11):2111-2121. PubMed ID: 36321278
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clinical Perspectives on the Use of Subcutaneous and Oral Formulations of Semaglutide.
    Gallwitz B; Giorgino F
    Front Endocrinol (Lausanne); 2021; 12():645507. PubMed ID: 34267725
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Impact of GLP-1 receptor agonists on blood pressure, heart rate and hypertension among patients with type 2 diabetes: A systematic review and network meta-analysis.
    Sun F; Wu S; Guo S; Yu K; Yang Z; Li L; Zhang Y; Quan X; Ji L; Zhan S
    Diabetes Res Clin Pract; 2015 Oct; 110(1):26-37. PubMed ID: 26358202
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trials.
    Mannucci E; Dicembrini I; Nreu B; Monami M
    Diabetes Obes Metab; 2020 Feb; 22(2):203-211. PubMed ID: 31595657
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Clinical features of symptomatic hypoglycemia observed after bariatric surgery.
    Nor Hanipah Z; Punchai S; Birriel TJ; Lansang MC; Kashyap SR; Brethauer SA; Schauer PR; Aminian A
    Surg Obes Relat Dis; 2018 Sep; 14(9):1335-1339. PubMed ID: 30001888
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Meta-analysis of head-to-head clinical trials comparing incretin-based glucose-lowering medications and basal insulin: An update including recently developed glucagon-like peptide-1 (GLP-1) receptor agonists and the glucose-dependent insulinotropic polypeptide/GLP-1 receptor co-agonist tirzepatide.
    Nauck MA; Mirna AEA; Quast DR
    Diabetes Obes Metab; 2023 May; 25(5):1361-1371. PubMed ID: 36700380
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Effects of endogenous GLP-1 and GIP on glucose tolerance after Roux-en-Y gastric bypass surgery.
    Svane MS; Bojsen-Møller KN; Nielsen S; Jørgensen NB; Dirksen C; Bendtsen F; Kristiansen VB; Hartmann B; Holst JJ; Madsbad S
    Am J Physiol Endocrinol Metab; 2016 Apr; 310(7):E505-14. PubMed ID: 26786780
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.